Author(s): Md. Abdul Sattar, A. Suneetha

Email(s): abdulsattar.bph@gmail.com

DOI: 10.5958/0974-360X.2019.00084.2   

Address: Md. Abdul Sattar*, A. Suneetha
Department of Pharmaceutical Analysis, Hindu College of Pharmacy, Amaravathi Road, Guntur-522002, Andhra Pradesh, India.
*Corresponding Author

Published In:   Volume - 12,      Issue - 2,     Year - 2019


ABSTRACT:
Numerous analysts have endeavored to utilize computer supported structure (Computer assisted design) or CAD and computer helped fabricating (CAM) to know a framework that provides a three-dimensional (3D) condition for recovery of tissues and organs. Therefore, a number of 3D printing advances, as well as stereo lithography, testimony displaying, inkjet-based printing and specific optical maser sintering are created. Since these 3D printing advancements use PCs for structure and manufacture, and that they will produce 3D platforms as structured; as a result, they will be institutionalized. Development of target tissues and organs needs the distance of fitting development factors; therefore manufacture of 3D platform frameworks that discharge these bimolecular has been investigated. The medication was created utilizing Pennsylvania-based Aprecia Pharmaceutical's exclusive ZipDose innovation,that expands once existing 3DP analysis did by MIT into creating fast dissolving materials. Even so empowering the generation of more and more compelling portion organizes; the innovation is at risk of have a key influence within the pharmaceutical business' flip towards low-volume generation and customized prescription. Going higher than and on the far side, on-request medicates printing offices at centers and drug stores, or maybe in patients' homes, may allow specialists to reinforce treatment by creating made-to-order dosing regimens. What are additional, parts might be made-to-order with singular hues, flavors and shapes to talk to person understanding which can support their adherence. As 3D printing capacities grow any, security and body issues ar attended and therefore the expense of the innovation falls besides contract manufacturers and pharmaceutical organizations that explore totally different avenues relating to these 3D printing developments are likely to choose up an aggressive edge. A new method was established for simultaneous estimation of Velpatasvir and Voxilaprevir by RP-HPLC method. The chromatographic conditions were successfully developed for the separation of Velpatasvir and Voxilaprevir by using Thermosil C18 column (4.0×125mm) 5.0µm, flow rate was 1ml/min, mobile phase ratio was (70:30 v/v) methanol: Sodium acetate buffer pH 3 (pH was adjusted with orthophosphoricacid), detection wavelength was 252nm. The retention times were found to be 2.566 mins and 3.417 mins. The linearity study of Velpatasvir and Voxilaprevir was found in concentration range of 5µg-25µg and 50µg-250µg and correlation coefficient (r2) was found to be 0.999 and 0.999, % recovery was found to be 99.56% and 99.48%, %RSD for repeatability was 0.86 and 0.82, % RSD for intermediate precision was 0.44 and 0.19 respectively. The precision study was precise, robust, and repeatable.LOD value was 3.17 and 5.68, and LOQ value was 0.0172 and 0.2125 respectively. Hence the suggested RP-HPLC


Cite this article:
Md. Abdul Sattar, A. Suneetha. RP-HPLC Method Development and Validation for Velpatasvir and Voxilaprevir by Simultaneous Determination in Bulk and Their Pharmaceutical Dosage Forms. Research J. Pharm. and Tech 2019; 12(2):477-482. doi: 10.5958/0974-360X.2019.00084.2

Cite(Electronic):
Md. Abdul Sattar, A. Suneetha. RP-HPLC Method Development and Validation for Velpatasvir and Voxilaprevir by Simultaneous Determination in Bulk and Their Pharmaceutical Dosage Forms. Research J. Pharm. and Tech 2019; 12(2):477-482. doi: 10.5958/0974-360X.2019.00084.2   Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-2-3


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available